Your account is not claimed yet. You can sign up with ORCID to claim your account.

Walid A M Elgaher (W A M Elgaher)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 8

Top Venues

Chemistry (Weinheim an der Bergstrasse, Germany)

Chemical science

ChemMedChem

ACS chemical biology

Helmholtz Institute for Pharmaceutical Research Saarland

Assiut University Faculty of Pharmacy (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Helmholtz Institute for Pharmaceutical Research Saarland Nov 1o 2019

Germany

Project leader :: Drug Design and Optimization

Education History

Assiut University Faculty of Pharmacy

Egypt

MSC :: Pharmaceutical Organic Chemistry

Publications

Fangfang Chen, Walid A M Elgaher, M Winterhoff, Konrad Büssow, Syed Fakhar-Ul-Hassnain Waqas, E Graner, Y Pires-Afonso, L Casares Perez, Laureano de la Vega, N Sahini, L Czichon, W Zobl, Thomas Zillinger, M Shehata, Stephan Pleschka, H Bähre, C Falk, Alessandro Michelucci, S Schuchardt, Wulf Blankenfeldt, Anna Katharina Herta Hirsch, Frank Pessler
Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism. Nature metabolism 4 (5) (2022)
Ravindra P Jumde, Melissa Guardigni, Robin M Gierse, Alaa Alhayek, Di Zhu, Zhoor Hamid, Sandra Johannsen, Walid A M Elgaher, Philipp J Neusens, Christian Nehls, Jörg Haupenthal, Norbert Reiling, Anna Katharina Herta Hirsch
Hit-optimization using target-directed dynamic combinatorial chemistry: development of inhibitors of the anti-infective target 1-deoxy-d-xylulose-5-phosphate synthase. Chemical science 12 (22) (2021)
Walid A M Elgaher, Mostafa M Hamed, Sascha Baumann, Jennifer Herrmann, Lorenz Siebenbürger, Jana Krull, Katarina Cirnski, Andreas Kirschning, Mark Brönstrup, Rolf Müller, Rolf Wolfgang Hartmann
Cystobactamid 507: Concise Synthesis, Mode of Action, and Optimization toward More Potent Antibiotics. Chemistry (Weinheim an der Bergstrasse, Germany) 26 (32) (2020)
Jörg Haupenthal, Yannik Kautz, Walid A M Elgaher, Linda Pätzold, Teresa Röhrig, Matthias W Laschke, Thomas Tschernig, Anna Katharina Herta Hirsch, Vadim Molodtsov, Katsuhiko S Murakami, Rolf Wolfgang Hartmann, Markus Bischoff
Evaluation of Bacterial RNA Polymerase Inhibitors in a Staphylococcus aureus-Based Wound Infection Model in SKH1 Mice. ACS infectious diseases 6 (10) (2020)
Philine Kirsch, Valentin Jakob, Walid A M Elgaher, Christine Walt, Kevin Oberhausen, Thomas F Schulz, Martin Empting
Discovery of Novel Latency-Associated Nuclear Antigen Inhibitors as Antiviral Agents Against Kaposi's Sarcoma-Associated Herpesvirus. ACS chemical biology 15 (2) (2020)
Alwin M Hartman, Varsha R Jumde, Walid A M Elgaher, Evelien M Te Poele, Lubbert Dijkhuizen, Anna Katharina Herta Hirsch
Potential Dental Biofilm Inhibitors: Dynamic Combinatorial Chemistry Affords Sugar-Based Molecules that Target Bacterial Glucosyltransferase. ChemMedChem 16 (1) (2020)
Federica Mancini, M Yagiz Unver, Walid A M Elgaher, Varsha R Jumde, Alaa Alhayek, Peer Lukat, Jennifer Herrmann, Martin D Witte, Matthias Köck, Wulf Blankenfeldt, Rolf Müller, Anna Katharina Herta Hirsch
Protein-Templated Hit Identification through an Ugi Four-Component Reaction*. Chemistry (Weinheim an der Bergstrasse, Germany) 26 (64) (2020)
Giambattista Testolin, Katarina Cirnski, Katharina Rox, Hans Prochnow, Verena Fetz, Charlotte Grandclaudon, Tim A Mollner, Alain Baiyoumy, Antje Ritter, Christian Leitner, Jana Krull, Joop van den Heuvel, Aurelie Vassort, Sylvie Sordello, Mostafa M Hamed, Walid A M Elgaher, Jennifer Herrmann, Rolf W Hartmann, Rolf Müller, Mark Brönstrup
Synthetic studies of cystobactamids as antibiotics and bacterial imaging carriers lead to compounds with high in vivo efficacy. Chemical science 11 (5) (2019)

Walid A M Elgaher.css-eqlu8i{font-size:small;padding-left:4px;} (W A M Elgaher)

Publication Activity (10 Years)

Top Topics

Top Venues

Walid A M Elgaher (W A M Elgaher)